Group One Trading
RGC icon

Group One Trading’s Regencell Bioscience RGC Stock Holding History

Group One Trading’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22K Sell
200
-700
-78% -$16.8K ﹤0.01% 7142
2026
Q1 		$22.9K Sell
900
-4,200
-82% -$119K ﹤0.01% 5869
2025
Q4 		$107K Sell
5,100
-1,700
-25% -$27.6K ﹤0.01% 4948
2025
Q3 		$105K Buy
+6,800
New +$97.5K ﹤0.01% 5300

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Group One Trading's RGC Position: Q2 2026 in Review

Group One Trading increased its Regencell Bioscience (RGC) stake by 169% in Q2 2026, buying an estimated $14.4K and bringing the position to 953 shares worth $5.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6673.

Group One Trading first reported a position in RGC in Q3 2025 and has held it in 3 quarters since. The position peaked at $9K in Q1 2026. 35 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

  • Group One Trading held 953 shares of Regencell Bioscience worth $5.8K as of Q2 2026.
  • Group One Trading bought 599 Regencell Bioscience shares in Q2 2026, an estimated $14.4K.
  • Regencell Bioscience made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6673 holding.
  • Group One Trading first reported a position in Regencell Bioscience in Q3 2025 and has held it in 3 quarters since.
  • Group One Trading's Regencell Bioscience position peaked at $9K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.